United States Biotechnology & Medical Research

Urogen Pharma Ltd (URGN)

Track

Over the past 90 days, Urogen Pharma Ltd has seen consistent selling activity from Chief Medical Officer Mark Schoenberg. These transactions, totaling approximately $142,560 in net value, occurred amid a 78.8% stock price increase. Following the May 2026 earnings report, insider activity has been exclusively focused on planned and proposed sales.
Ticker: URGN Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Urogen Pharma Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 9 Jul 2026
Value US$3,403,454.44 | Price 251.60 | Shares 26,600 (-2.1%)
Proposed sale 9 Jul 2026
Value US$1,396,294.46 | Price 76.00 | Shares 68,469
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-10 2026-07-09 PlS Planned sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
26,600 -2.1%
251.60
US$3,403,454 		26,600 -2.1% 251.60 US$3,403,454
2026-07-09 2026-07-09 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
68,469
76.00
US$1,396,294 		68,469 76.00 US$1,396,294
2026-06-24 2026-06-22 PlS Planned sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
34,817 +10.3%
220.29
US$2,286,229 		34,817 +10.3% 220.29 US$2,286,229
2026-06-22 2026-06-22 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
10,000
35.01
US$350,143 		10,000 35.01 US$350,143
2026-06-09 2026-06-08 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
5,222 -3.6%
27.30
US$142,561 		5,222 -3.6% 27.30 US$142,561
2026-06-09 2026-06-08 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
5,222
26.85
US$140,211 		5,222 26.85 US$140,211
2026-05-11 2026-05-08 PlS Planned sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
10,000 -6.9%
30.00
US$300,000 		10,000 -6.9% 30.00 US$300,000
2026-05-08 2026-05-08 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
10,000
30.00
US$300,048 		10,000 30.00 US$300,048
2026-02-11 2026-02-03 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
3,217 -5.5%
19.69
US$63,343 		3,217 -5.5% 19.69 US$63,343
2026-02-11 2026-02-03 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
1,608 -3.0%
19.69
US$31,662 		1,608 -3.0% 19.69 US$31,662
2026-02-11 2026-02-03 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
2,654 -4.8%
19.69
US$52,257 		2,654 -4.8% 19.69 US$52,257
2026-02-04 2026-02-03 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
3,686 -2.5%
19.69
US$72,577 		3,686 -2.5% 19.69 US$72,577
2026-02-04 2026-02-03 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,843 -1.2%
19.69
US$36,289 		1,843 -1.2% 19.69 US$36,289
2026-02-04 2026-02-03 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
3,686 -2.5%
19.69
US$72,577 		3,686 -2.5% 19.69 US$72,577
2026-02-04 2026-02-03 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,843 -1.2%
19.69
US$36,289 		1,843 -1.2% 19.69 US$36,289
2026-02-04 2026-02-03 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,844 -1.2%
19.69
US$36,308 		1,844 -1.2% 19.69 US$36,308
2026-02-03 2026-02-02 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
13,333
19.61
US$261,460 		13,333 19.61 US$261,460
2025-11-20 2025-11-19 PlS Planned sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
10,000 -6.7%
25.00
US$250,000 		10,000 -6.7% 25.00 US$250,000
2025-11-19 2025-11-19 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
10,000
25.00
US$250,005 		10,000 25.00 US$250,005
2025-10-09 2025-10-08 S Sale
2.2
Degnan Chris

Chief Financial Officer

Officer
2,203 -49.1%
16.85
US$37,121 		2,203 -49.1% 16.85 US$37,121
2025-09-09 2025-09-08 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
871
18.88
US$16,444 		871 18.88 US$16,444
2025-09-09 2025-09-08 PrS Proposed sale
2.0
Smith Jason Drew

Officer

Officer
1,520
18.88
US$28,698 		1,520 18.88 US$28,698
2025-09-09 2025-09-08 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
871 -0.6%
19.11
US$16,645 		871 -0.6% 19.11 US$16,645
2025-09-09 2025-09-08 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
1,520 -3.4%
19.11
US$29,047 		1,520 -3.4% 19.11 US$29,047
2025-08-13 2025-08-11 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
10,000 -6.3%
17.69
US$176,900 		10,000 -6.3% 17.69 US$176,900
2025-07-30 2025-07-28 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
5,149 -3.2%
19.14
US$98,552 		5,149 -3.2% 19.14 US$98,552
2025-07-30 2025-07-28 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
7,522 -15.3%
19.14
US$143,971 		7,522 -15.3% 19.14 US$143,971
2025-07-29 2025-07-28 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
5,149
18.95
US$97,574 		5,149 18.95 US$97,574
2025-07-29 2025-07-28 PrS Proposed sale
2.0
Smith Jason Drew

Officer

Officer
7,522
18.95
US$142,542 		7,522 18.95 US$142,542
2025-06-11 2025-06-09 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
5,162 -3.3%
7.37
US$38,044 		5,162 -3.3% 7.37 US$38,044
2025-06-10 2025-06-09 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
5,162
7.37
US$38,044 		5,162 7.37 US$38,044
2025-02-04 2025-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,896 -1.3%
11.14
US$21,121 		1,896 -1.3% 11.14 US$21,121
2025-02-04 2025-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,896 -1.3%
11.14
US$21,121 		1,896 -1.3% 11.14 US$21,121
2025-02-04 2025-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
759 -0.5%
11.14
US$8,455 		759 -0.5% 11.14 US$8,455
2025-02-04 2025-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
2,767 -7.8%
11.14
US$30,824 		2,767 -7.8% 11.14 US$30,824
2025-02-04 2025-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
3,354 -10.1%
11.14
US$37,364 		3,354 -10.1% 11.14 US$37,364
2025-02-04 2025-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
1,258 -4.5%
11.14
US$14,014 		1,258 -4.5% 11.14 US$14,014
2024-09-12 2024-09-09 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
1,521 -5.7%
13.08
US$19,895 		1,521 -5.7% 13.08 US$19,895
2024-09-12 2024-09-09 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
859 -0.6%
13.08
US$11,236 		859 -0.6% 13.08 US$11,236
2024-09-10 2024-09-09 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
859
13.23
US$11,365 		859 13.23 US$11,365
2024-06-11 2024-06-10 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
5,153
13.21
US$68,071 		5,153 13.21 US$68,071
2024-06-11 2024-06-10 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
5,153 -3.4%
13.08
US$67,401 		5,153 -3.4% 13.08 US$67,401
2024-03-20 2024-03-18 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
12,000 -7.9%
14.05
US$168,600 		12,000 -7.9% 14.05 US$168,600
2024-03-18 2024-03-18 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
12,000
14.05
US$168,600 		12,000 14.05 US$168,600
2024-02-02 2024-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
3,328 -12.4%
15.74
US$52,383 		3,328 -12.4% 15.74 US$52,383
2024-02-02 2024-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
1,248 -5.9%
15.74
US$19,644 		1,248 -5.9% 15.74 US$19,644
2024-02-02 2024-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
417 -2.2%
15.74
US$6,564 		417 -2.2% 15.74 US$6,564
2024-02-02 2024-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,894 -1.2%
15.74
US$29,812 		1,894 -1.2% 15.74 US$29,812
2024-02-02 2024-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
758 -0.5%
15.74
US$11,931 		758 -0.5% 15.74 US$11,931
2024-02-02 2024-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,137 -0.8%
15.74
US$17,896 		1,137 -0.8% 15.74 US$17,896
2024-02-01 2024-01-31 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
3,789
15.83
US$59,980 		3,789 15.83 US$59,980
2024-02-01 2024-01-31 PrS Proposed sale
2.0
Smith Jason Drew

Officer

Officer
4,993
15.83
US$79,039 		4,993 15.83 US$79,039
2023-09-05 2023-08-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
3,800 -17.1%
18.01
US$68,438 		3,800 -17.1% 18.01 US$68,438
2023-02-02 2023-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
661 -0.4%
10.12
US$6,689 		661 -0.4% 10.12 US$6,689
2023-02-02 2023-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
991 -0.7%
10.12
US$10,029 		991 -0.7% 10.12 US$10,029
2023-02-02 2023-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
248 -0.2%
10.12
US$2,510 		248 -0.2% 10.12 US$2,510
2023-02-02 2023-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
1,227 -8.1%
10.12
US$12,417 		1,227 -8.1% 10.12 US$12,417
2023-02-02 2023-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
409 -3.1%
10.12
US$4,139 		409 -3.1% 10.12 US$4,139
2022-11-02 2022-10-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
258 -1.1%
11.85
US$3,057 		258 -1.1% 11.85 US$3,057
2022-09-02 2022-08-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
3,606 -22.8%
7.21
US$25,999 		3,606 -22.8% 7.21 US$25,999
2022-08-25 2022-08-01 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
259 -1.1%
7.81
US$2,023 		259 -1.1% 7.81 US$2,023
2022-05-03 2022-04-30 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
254 -1.1%
6.62
US$1,681 		254 -1.1% 6.62 US$1,681
2022-02-02 2022-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
414 -5.3%
7.58
US$3,138 		414 -5.3% 7.58 US$3,138
2022-02-02 2022-01-31 S Sale
2.2
Barrett Elizabeth A.

Chief Executive Officer

Officer
5,960 -1.9%
7.58
US$45,177 		5,960 -1.9% 7.58 US$45,177
2022-02-02 2022-01-31 S Sale
2.2
Barrett Elizabeth A.

Chief Executive Officer

Officer
2,235 -0.7%
7.58
US$16,941 		2,235 -0.7% 7.58 US$16,941
2022-02-02 2022-01-31 S Sale
3.5
Henderson Molly

Chief Financial Officer

Officer
331 -5.9%
7.58
US$2,509 		331 -5.9% 7.58 US$2,509
2022-02-02 2022-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,099 -4.5%
7.58
US$8,330 		1,099 -4.5% 7.58 US$8,330
2022-02-02 2022-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
275 -1.2%
7.58
US$2,084 		275 -1.2% 7.58 US$2,084
2022-01-28 2022-01-26 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
111 -0.5%
8.09
US$898 		111 -0.5% 8.09 US$898
2022-01-07 2022-01-04 S Sale
2.2
Barrett Elizabeth A.

Chief Executive Officer

Officer
46,968 -13.6%
9.15
US$429,757 		46,968 -13.6% 9.15 US$429,757
2021-12-02 2021-11-30 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
3,803 -35.1%
12.03
US$45,750 		3,803 -35.1% 12.03 US$45,750
2021-12-02 2021-11-30 S Sale
3.5
Henderson Molly

Chief Financial Officer

Officer
2,587 -34.5%
12.03
US$31,122 		2,587 -34.5% 12.03 US$31,122
2021-11-19 2021-11-18 B Purchase
2.1
Schoenberg Mark

Chief Medical Officer

Officer
160 +0.7%
13.10
US$2,096 		160 +0.7% 13.10 US$2,096
2021-11-02 2021-11-01 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
258 -1.2%
17.16
US$4,427 		258 -1.2% 17.16 US$4,427
2021-10-28 2021-10-27 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
107 -0.5%
16.32
US$1,746 		107 -0.5% 16.32 US$1,746
Explore more

More insider trading research around Urogen Pharma Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America